Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors

被引:1
|
作者
Boehm, Kevin [1 ,2 ]
Schulze-Niemand, Eric [1 ]
Kaehne, Thilo [1 ]
Siddiqui, Elisa [1 ]
Taeger, Christian [1 ]
Ramsbeck, Daniel [2 ]
Buchholz, Mirko [2 ]
Naumann, Michael [1 ,3 ,4 ]
机构
[1] Otto Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany
[2] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Drug Design & Target Validat MWT, Bioctr, Halle, Germany
[3] Otto Guericke Univ, Inst Expt Internal Med, Med Fac, Leipziger Str 44, D-39120 Magdeburg, Germany
[4] PerioTrap Pharmaceut GmbH, Bioctr, Halle, Germany
关键词
chemical synthesis; drug design; papain-like protease; ubiquitin-specific proteases; USP2; SMALL-MOLECULE INHIBITOR; UBIQUITIN; SPECIFICITY; DISCOVERY; CELLS;
D O I
10.1002/ardp.202200661
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ubiquitin-specific proteases represent a family of enzymes that catalyze the cleavage of ubiquitin from specific substrate proteins to regulate their activity. USP48 is a rarely studied USP, which has recently been linked to inflammatory signaling via regulation of the transcription factor nuclear factor kappa B. Nonetheless, a crystal structure of USP48 has not yet been resolved and potent inhibitors are not known. We screened a set of 14 commercially available USP inhibitors for their activity against USP48 and identified the USP2 inhibitor "ML364" as a candidate for further optimization. Using a ligand-based approach, we derived and synthesized a series of ML364 analogs. The IC50 concentrations of the new compounds to inhibit USP48 were determined in a deubiquitinylase activity assay by measuring the fluorescence intensity using tetra-ubiquitin rhodamine110 as substrate. A compound containing a carboxylic acid functionalization (17e) inhibited USP48 activity toward tetra-ubiquitin rhodamine110 with an IC50 of 12.6 mu M. Further structure-based refinements are required to improve the inhibition activity and specificity.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
    Lu, Guo-Liang
    Tong, Amy S. T.
    Conole, Daniel
    Sutherland, Hamish S.
    Choi, Peter J.
    Franzblau, Scott G.
    Upton, Anna M.
    Lotlikar, Manisha U.
    Cooper, Christopher B.
    Denny, William A.
    Palmer, Brian D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
  • [32] Synthesis and Structure-Activity Relationships of a Class of Sodium Iodide Symporter Function Inhibitors
    Waltz, Fanny
    Pillette, Lucie
    Verhaeghe, Elodie
    Ambroise, Yves
    CHEMMEDCHEM, 2011, 6 (10) : 1775 - 1777
  • [33] Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors
    Lv, Peng-Cheng
    Sun, Juan
    Luo, Yin
    Yang, Ying
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4657 - 4660
  • [34] Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors
    Lombardo, LJ
    Camuso, A
    Clark, J
    Fager, K
    Gullo-Brown, J
    Hunt, JT
    Inigo, I
    Kan, D
    Koplowitz, B
    Lee, F
    McGlinchey, K
    Qian, LG
    Ricca, C
    Rovnyak, G
    Traeger, S
    Tokarski, J
    Williams, DK
    Wu, LI
    Zhao, YF
    Manne, V
    Bhide, RS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1895 - 1899
  • [35] Design, Synthesis, and Structure-Activity Relationships of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors
    Colis, Laureen
    Ernst, Glen
    Sanders, Sara
    Liu, Hester
    Sirajuddin, Paul
    Peltonen, Karita
    DePasquale, Michael
    Barrow, James C.
    Laiho, Marikki
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4950 - 4961
  • [36] Design, synthesis and structure-activity relationships of carbohydrazide based cathepsin K inhibitors
    Thompson, SK
    Tomaszek, TA
    Tew, DG
    Levy, MA
    Smith, WW
    Zhao, B
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    DesJarlais, RL
    Abdel-Meguid, SS
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U287 - U287
  • [37] Synthesis and structure-activity relationships of tyrosine-based inhibitors of autotaxin (ATX)
    East, James E.
    Kennedy, Andrew J.
    Tomsig, Jose L.
    De Leon, Alexandra R.
    Lynch, Kevin R.
    Macdonald, Timothy L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7132 - 7136
  • [38] Design, synthesis and structure-activity relationships of potent B-RAF inhibitors
    Namdev, Nivedita
    Lapierre, Jean-Marc
    Liu, Yanbin
    Wu, Hui
    Brassard, Chris
    Westlund, Neil
    Tandon, Manish
    Link, Jeff
    Kizer, Darin
    Nicewonger, Robb
    Bresciano, Karen
    Hall, Terence
    Szwaya, Jeff
    Chen, Chang-Rung
    France, Dennis
    Ashwell, Mark A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [39] Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors
    Ishibuchi, S
    Morimoto, H
    Oe, T
    Ikebe, T
    Inoue, H
    Fukunari, A
    Kamezawa, M
    Yamada, I
    Naka, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (07) : 879 - 882
  • [40] Structure-activity relationships of selective GABA uptake inhibitors
    Hog, Signe
    Greenwood, Jeremy R.
    Madsen, Karsten B.
    Larsson, Orla M.
    Frolund, Bente
    Schousboe, Arne
    Krogsgaard-Larsen, Povl
    Clausen, Rasmus P.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (17) : 1861 - 1882